Genome Projects and Gene Therapy: Gateways to Next Generation Biological Weapons

Military Medicine

Volumn 168, Issue 11, 2003, Pages 864-871

  Black III, John Logan ^a,b,c  

^a MAYO CLINIC   (United States)

^b WRTOAO ^*  (United States)

^c ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; LIPOSOME; NAKED DNA; OLIGONUCLEOTIDE; PRODRUG; RETROVIRUS VECTOR; VIRUS VECTOR;

ADENOVIRUS; ANTIGEN EXPRESSION; BACTERIAL GENOME; BIOLOGICAL WARFARE; CLASSIFICATION; DNA SEQUENCE; DNA TRANSFER; DNA VECTOR; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENE REPLACEMENT THERAPY; GENE SEQUENCE; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HERPES SIMPLEX VIRUS VECTOR; HUMAN; HUMAN GENOME; MEDICAL GENETICS; MORBIDITY; MORTALITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLANT DISEASE; PLASMID; POLICY; POLITICS; PUBLIC HEALTH; RETROVIRUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EID: 0242552616     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.11.864     Document Type: Review

References (45)

1. Fraser CM, Dando MR: Genomics and future biological weapons; the need for preventive action by the biomedical community. Nat Genet 2001; 29: 253-6.
2. Anonymous: Gene warfare-unless we keep our guard up. Lancet 1996; 348: 1183.
3. International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
4. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome, Science 2001; 291: 1304-51.
5. Drews J: Research and development: basic science and pharmaceutical innovation. Nat Biotechnol 1999; 17: 406.
6. Drews J: Drug discovery: a historical perspective. Science 2000; 287: 1960-4.
7. Fleischmann RD, Adams MD, White O, et al: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995; 269: 496-512.
8. Fraser CM, Gocayne JD, White O, et al: The minimal gene complement of Mycoplasma genitalium Science 1995; 270: 397-403.
9. Cherry JM, Ball C, Weng S, et al: Genetic and physical maps of Saccharomyces cerevisiae. Nature 1997; 387: 67-73.
10. Bult CM, White O, Olsen GJ, et al: Complete genome sequence of the methanogenic archaeon, Methanococcus jannoschii Science 1996; 273: 1058-73.
11. Blattner FR, Plunkett G 3rd, Bloch CA, et al: The complete genome sequence of Escherichia coli K-12. Science 1997; 277: 1453-74.
12. Cole ST, Brosch R, Parkhill J, et al: Deciphering the biology of Mycobacterium tuberculosa from the complete genome sequence. Nature 1998; 393: 537-44.
13. The Caenorhabditis elegans Sequencing Consortium: Genomic sequence of the nematode C, elegans: a platform for investigating biology. Science 1998; 282: 2012-8.
14. Adams MD, Celniker SE, Holt RA, et al: The genome sequence of Drosophila melanogaster. Science 2000; 287: 2185-95.
15. Parkhill J, Wren BW, Thomson NR, et al: Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001; 413: 523-7.
16. Russell SJ: Science, medicine, and the future; gene therapy. Br Med J 1997; 315: 1289-92.
17. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: pathways from concept to reality. Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system, Neurosurgery 1997; 40: 805-13.
18. Gojo S, Cooper DKC, Iacomini J, LeGuern C: Gene therapy and transplantation. Transplantation 2000; 69: 1995-9.
19. Kouraklis G: Gene therapy for cancer: from the laboratory to the patient. Dig Dis Sci 2000; 45: 1045-52.
20. Springer CJ, Niculescu-Duvaz I: Prodrug-activating systems in suicide gene therapy. J Clin Invest 2000; 105: 1161-7.
21. Bestor TH: Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000; 105: 409-11.
22. Smaglik P: Gene therapy institute denies that errors led to trial death. Nature 2000; 403: 820.
23. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: pathways from concept to reality. Part I: Target disorders and concept approaches to gene therapy of the central nervous system, Neurosurgery 1997; 40: 789-804.
24. Sapolsky RM, Steinberg GK: Gene therapy using viral vectors for acute neurologic insults. Neurology 1999; 53: 1922-31.
25. Kroshus TJ, Bolman RM, Dalmasso AP, et al: Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61: 1513-21.
26. Coffin JM: Retroviridae and their replication. In Virology, Edited by Fields BN. New York. Raven Press Ltd, 1990.
27. Watson JD, Hopkins NH, Robert JW, Steitz JA, Weiner AM: Molecular Biology of the Gene, Ed 4. New York, Benjamin-Cummings, 1988.
28. Suhr ST, Gage FH: Gene therapy in the central nervous system: the use of recombinant retroviruses. Arch Neurol 1999; 56: 287-92.
29. Herrmann F: Cancer gene therapy: principles problems and perspectives. J Mol Med 1995; 73: 157-63.
30. Gelinas C, Temin HM: Non-defective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc Natl Acad Sci USA 1986; 83: 9211-5.
31. Miller AD: Retrovirus packaging cells. Hum Gene Ther 1990; 1: 5-14.
32. Hermiston T: Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer. J Clin Invest 2000; 105: 1169-72.
33. Zhu N, Liggitt D, Liu Y, Debs R: Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-11.
34. Agha-Mohammadi S, Lotze MT: Regulatable systems; applications in gene therapy and replicating viruses. J Clin Invest 2000; 105: 1177-83.
35. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-89.
36. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW: Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1996; 15: 239-43.
37. No D, Yao T-P, Evans RM: Eedysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 3346-51.
38. Rivera VM, Clackson T, Natesan S, et al: A humanized system for pharmacologic control of gene expression. Nat Med 1996; 2: 1028-32.
39. Kennedy BN, Vihtelic T, Checkley L, Vaughan KT, Hyde DR: Isolation of a zebra fish rhodopsin promoter to generate a transgenic zebra fish line expressing enhanced green fluorescent protein in rod photoreceptors. J Biol Chem 2001; 276: 14037-43.
40. Kurtz TW, Gardner DG: Transcription-modifying drugs: a new frontier in the treatment of the central hypertension, Hypertension 1998; 32: 380-6.
41. Ashburner M, Ball CA, Blake JA, et al: Gene ontology: tool for the unification of biology: The Gene Ontology Consortium, Nat Genet 2000; 25: 25-9.
42. Noah DL, Sobel AL, Ostroff SM, Kildew JA: Biological warfare training: infectious disease outbreak differentiation criteria. Milit Med 1998; 163: 198-201.
43. Zilinskas RA: Report to U.S. House of Representatives Committee on Governmental Reform, Subcommittee on National Security, Veterans Affairs, and International Relations. Combating Terrorism: Assessing the Threat of BioTerrorism. October 20, 1999.
44. Makin S-I, Cheun HI, Watarai M, Uchida I, Takeshi K: Detection of anthrax spores from the air by real-time PCR. Lett Appl Microbiol 2001; 33: 237-40.
45. Cello J, Paul AV, Wimmer E: Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 2002; 297: 1016-8.